Updated
Johnson & JohnsonJNJ · Healthcare
$282.10+2.11%
Market cap$679.1B
IndustryDrug Manufacturers - General
Johnson & Johnson (JNJ) Superinvestor holders
52 of the superinvestors we track hold Johnson & Johnson (JNJ) in their latest 13F filings, $12.2B in total.
Summary
The largest holder is Ken Fisher (Fisher Investments), with $3.9B, 1.1% of the portfolio.
In their latest quarter: 3 opened a new position, 13 added, 28 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Ken Fisher Fisher Investments |
Added | 14,837,126 | $3.9B | 1.1% | Q3 2026 |
| Jeremy Grantham GMO |
Trimmed | 7,110,133 | $1.8B | 4.1% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 5,343,260 | $1.4B | 1.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 2,989,537 | $759M | 0.6% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 2,907,803 | $738M | 0.3% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 2,064,646 | $524M | 0.9% | Q2 2026 |
| Donald Yacktman Yacktman Asset Management |
Added | 1,261,078 | $334M | 4.0% | Q3 2026 |
| Acadian Acadian Asset Management |
Trimmed | 1,154,808 | $306M | 0.4% | Q3 2026 |
| Arrowstreet Capital | Added | 1,127,893 | $286M | 0.1% | Q2 2026 |
| Mark Donovan Boston Partners |
Trimmed | 1,113,805 | $283M | 0.3% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 704,715 | $179M | 0.5% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 688,542 | $175M | 0.4% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 687,227 | $175M | 0.1% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 669,135 | $170M | 0.7% | Q2 2026 |
| Tom Gayner Markel Group Inc. |
Held | 610,800 | $162M | 1.3% | Q3 2026 |
| Man Group Man Group plc |
Added | 517,830 | $132M | 0.2% | Q2 2026 |
| Alger Fred Alger Management |
Added | 444,151 | $113M | 0.4% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Trimmed | 423,010 | $107M | 1.0% | Q2 2026 |
| Tom Steyer Farallon Capital Management LLC |
Added | 408,000 | $104M | 0.6% | Q2 2026 |
| Harding Loevner | Added | 377,680 | $96M | 0.9% | Q2 2026 |
| David Vogel Voloridge Investment Management |
New position | 363,570 | $92M | 0.4% | Q2 2026 |
| Charles Brandes Brandes Investment Partners, LP |
Trimmed | 276,623 | $70M | 0.5% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 229,968 | $58M | 1.1% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 200,512 | $51M | 0.1% | Q2 2026 |
| Tweedy, Browne Tweedy, Browne Company |
Trimmed | 190,945 | $51M | 4.1% | Q3 2026 |
| Josef Lakonishok LSV Asset Management |
Trimmed | 109,623 | $29M | 0.1% | Q3 2026 |
| Mario Gabelli GAMCO Investors |
Trimmed | 80,050 | $20M | 0.2% | Q2 2026 |
| Prem Watsa Fairfax Financial Holdings |
Held | 73,400 | $19M | 0.7% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 62,412 | $16M | 0.2% | Q2 2026 |
| Neil Hennessy Hennessy Advisors |
Trimmed | 48,200 | $13M | 0.5% | Q3 2026 |
| John Rogers Ariel Investments |
Trimmed | 35,393 | $9M | 0.1% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 34,909 | $9M | 0.0% | Q2 2026 |
| George Soros Soros Fund Management |
Trimmed | 34,019 | $9M | 0.1% | Q2 2026 |
| Wasatch Wasatch Global Investors |
Trimmed | 24,999 | $7M | 0.0% | Q3 2026 |
| Howard Gleicher Aristotle Capital Management |
Held | 25,712 | $7M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Added | 25,172 | $6M | 0.0% | Q2 2026 |
| Robert Olstein Olstein Capital Management |
Trimmed | 24,500 | $6M | 1.3% | Q1 2026 |
| Eric Marshall Hodges Capital Management |
Added | 23,026 | $6M | 0.4% | Q2 2026 |
| Will Nasgovitz Heartland Advisors |
Trimmed | 22,532 | $6M | 0.3% | Q2 2026 |
| Dodge & Cox | Held | 20,947 | $5M | 0.0% | Q2 2026 |
| Brandon Haley Holocene Advisors |
New position | 18,956 | $5M | 0.0% | Q2 2026 |
| Alan Breed Edgewood Management |
Held | 18,371 | $5M | 0.0% | Q2 2026 |
| Mark Boyar Boyar Asset Management |
Trimmed | 15,947 | $4M | 2.6% | Q3 2026 |
| Murray Stahl Horizon Kinetics LLC |
Trimmed | 15,508 | $4M | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Trimmed | 11,747 | $3M | 0.1% | Q2 2026 |
| Jensen Investment Management | Trimmed | 8,797 | $2M | 0.1% | Q2 2026 |
| Robert Torray Torray Investment Partners |
Held | 4,141 | $1M | 0.1% | Q3 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 2,741 | $696,197 | 0.0% | Q2 2026 |
| Conestoga Conestoga Capital Advisors |
Held | 1,860 | $492,416 | 0.0% | Q3 2026 |
| David Katz Matrix Asset Advisors |
Held | 1,622 | $429,408 | 0.0% | Q3 2026 |
| Tom Russo Gardner Russo & Quinn |
Trimmed | 1,112 | $282,415 | 0.0% | Q2 2026 |
| Chris Bloomstran Semper Augustus Investments Group |
New position | 794 | $201,652 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 51 |
| Q1 2026 | 52 |
| Q4 2025 | 50 |
| Q3 2025 | 48 |
| Q2 2025 | 50 |
| Q1 2025 | 50 |
| Q4 2024 | 51 |
| Q3 2024 | 48 |
Questions about Johnson & Johnson
Which superinvestors own Johnson & Johnson?
52 of the superinvestors we track hold Johnson & Johnson (JNJ) in their latest 13F filings, $12.2B in total. Ken Fisher, Jeremy Grantham, Hersh Cohen, Paul Marshall, Cliff Asness, Ensign Peak.
Who is the largest superinvestor holder of JNJ?
The largest holder is Ken Fisher (Fisher Investments), with $3.9B, 1.1% of the portfolio.
From Johnson & Johnson's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.